www.genomeweb.com/molecular-diagnostics/personal-genome-diagnostics-gets-fda-breakthrough-device-designation-liquid

Jul 24, 2018 ... NEW YORK (GenomeWeb) – Personal Genome Diagnostics said today ... and Guardant Health said in February that the FDA had granted its ...

hub.jhu.edu/2017/12/14/liquid-biopsy-results-differ-between-lab-providers

Dec 14, 2017 ... ... panels compared were the Guardant360, from Guardant Health, Inc., ... and the PlasmaSELECT panel from Personal Genome Diagnostics, ...

www.forbes.com/sites/victoriaforster/2018/07/19/liquid-biopsy-controversy-rages-on

Jul 19, 2018 ... These were the Guardant360 from Guardant Health Inc. and PlasmaSELECT- R64 from Personal Genome Diagnostics. Worryingly, the ...

www.forbes.com/sites/victoriaforster/2017/12/15/oncologists-beware-expensive-liquid-biopsy-tests-to-analyze-cancer-produce-conflicting-results

Dec 15, 2017 ... A scientist prepares samples for DNA analysis. ... from Guardant Health Inc. and PlasmaSELECT-R64 from Personal Genome Diagnostics, ...

investors.guardanthealth.com/static-files/40f7ae54-8743-477a-92bf-79eafd677f95

Sep 21, 2018 ... Guardant Health, Inc. (the “Company”) is a leading precision oncology ...... lawsuits against Personal Genome Diagnostics, Inc. (“Personal Genome ... Genome Diagnostics filed two petitions for post-grant review with the PTAB ...

investors.guardanthealth.com/static-files/45d8956c-21d7-4c47-b515-3fe8e6883cfc

Sep 21, 2018 ... Proceeds to Guardant Health, Inc., before expenses ...... Scientific Inc., Illumina, Inc., Personal Genome Diagnostics, Inc., Qiagen N.V. and Sysmex Inostics. ...... of ctDNA to differentiate between early cancerous versus benign ...

www.focr.org/news/genomeweb-guardant-silent-tmb-plans-study-adds-evidence-immunotherapy-prediction-blood

Jul 31, 2018 ... ... the ability of Guardant Health's Guardant360 assay to predict responsiveness ... Ellen V. Sigal · Marlene A. Malek · Jeff Allen · Ryan Hohman · Heather ... The company declined to comment on its internal commercial progress ... Personal Genome Diagnostics, Thermo Fisher Scientific, Illumina, Guardant ...

www.cancertherapyadvisor.com/prostate-cancer/liquid-biopsy-prostate-cancer-trustworthy/article/745224

Feb 20, 2018 ... Commercially available circulating tumor DNA (ctDNA) gene ... cancer to Guardant Health, Inc and Personal Genome Diagnostics, Inc for ...

ascopubs.org/doi/full/10.1200/EDBK_199765

The Therascreen EGFR Plasma RGQ PCR test (Qiagen Inc., Venlo, the ... antibody to chemotherapy versus chemotherapy alone indicated that multiple KRAS, NRAS, ..... are Guardant360 (Guardant Health, Redwood City, CA) and FoundationACT ... CA), and PlasmaSELECT (Personal Genome Diagnostics, Baltimore, MD).